The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk. - Wikidata - awgldk - TriplyDB

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

http://www.wikidata.org/entity/Q35173735

about

Associations between estrogen receptor-beta polymorphisms and endometriosis risk: a meta-analysis A new method for discovering disease-specific MiRNA-target regulatory networks Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.Social memory associated with estrogen receptor polymorphisms in women Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness.Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis.

P2860

Q34265983-ED3162C7-2609-4AF1-B2F5-F673D29F677B Q35302572-EC98C313-BB3F-4571-ABA3-5A91B19FB7F2 Q36250030-1CB8991A-A71A-44FC-B087-9A8EFC52BA11 Q36945120-4766C9DB-1189-43D5-9D87-19FE95D69A7A Q38620751-B4B74155-421C-4469-B16B-94C80A8F593E Q42367688-721A928E-B599-4450-AE4A-A62B5FAF671A Q42370692-5C9B0020-13CE-48AA-BF03-BAC9D5A1A6D0 Q47095480-12C68141-655A-4728-A594-61F2659F1884

P2860

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

http://www.wikidata.org/entity/Q35173735

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@ast

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@en

type

label

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@ast

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@en

prefLabel

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@ast

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@en

P1433

Q35173735-5AC477CB-7224-4595-8BF2-FD319A86928E

P1476

Q35173735-36F8A22A-F168-4A00-A4B3-F745B9C35DC4

P2093

Q35173735-24597273-380F-4306-A677-0829492673DD

Q35173735-332E9168-87E3-4642-8781-BEAEED99C82A

Q35173735-35A3FC49-70A9-4E6C-BB5B-05B0E702EC10

Q35173735-ECEAFA2B-1E1A-4A1D-AD2E-C2AB977D71A1

P2860

Q35173735-07F1D73B-AC0E-4E4B-B54B-1550180DF6D7

Q35173735-0B685393-474F-4906-8020-A65EE5DBF64F

Q35173735-0C2CC479-E3DD-4586-9073-74A0570FED0B

Q35173735-14F5533F-01F4-44ED-B25B-C03E0CAB7B04

Q35173735-21344F1A-2525-49EA-BF04-F4516BB592EC

Q35173735-33A2993A-F9F0-4B8E-9B0D-94A461D2FB73

Q35173735-4250943F-D1FA-4535-BF55-9680396E64AD

Q35173735-457B8DF5-82E8-476F-8640-D2D33F9A2CC0

Q35173735-4C07C015-9B50-4D91-BDEF-00DAE70F2198

Q35173735-590775A3-5ADA-4AAE-AA8A-37020973D922

P2888

Q35173735-A7A9128F-9D06-4FDD-806C-BA24D9E619BD

P304

Q35173735-4E99C4DE-6499-42FF-B917-D679FB0837E3

P31

Q35173735-37b8d2c5-8df0-4165-b787-e7fff0086a9d

Q35173735-C8D8EAD5-3509-40DF-8C0B-696D61A33E6B

P356

Q35173735-BAC8C7E3-3951-4F49-8450-C72089A1D12A

P433

Q35173735-556C2507-951F-4446-8B90-B87FEA94895F

P478

Q35173735-6AD91927-D902-42E2-A940-3FE0D9B02472

P577

Q35173735-701C9377-2653-4C85-B3C5-5DAD9116F463

P698

Q35173735-F2255771-75EB-4BA4-80CD-F0FFA8844442

P356

S13277-014-2086-7

P1433

P1476

The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

@en

P2093

Ani Wang

http://www.w3.org/2001/XMLSchema#string

Chenying Fu

http://www.w3.org/2001/XMLSchema#string

Guozhen Qiu

http://www.w3.org/2001/XMLSchema#string

Wen-Qi Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Operating characteristics of a rank correlation test for publication bias

Meta-analysis in clinical trials

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate

Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study.

Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy

ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis

Role of estrogens in development of prostate cancer.

The choice of a genetic model in the meta-analysis of molecular association studies.

P2888

s13277-014-2086-7

P304

8319-8328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-014-2086-7

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24859835

http://www.w3.org/2001/XMLSchema#string